Search

everythinglearnresearchcommunity

for

Search:↓

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Alopecia areata is a common autoimmune disease affecting hair follicles, with unclear causes and a need for better treatments.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Alopecia areata is linked to autoimmune antibodies.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Pediatric systemic lupus erythematosus is a severe autoimmune disease in children requiring early diagnosis and comprehensive management.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

New genetic discoveries in alopecia areata could lead to better treatments.

Certain immune cells may cause hair loss by reacting to stressed hair follicles.

JAK inhibitors like baricitinib and ritlecitinib are effective new treatments for severe alopecia areata.

Early intervention and patient education are crucial for managing alopecia areata.

Early diagnosis and treatment are crucial for managing alopecia areata, morphea, and psoriasis.

Fine hairs improve male pattern baldness treatment, alopecia areata causes remain unknown, and hair can recover from dye damage over time.

Cicatricial alopecia may be caused by immune attacks on hair follicles, gland issues, or stem cell damage.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.